Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $788.59 billion, total revenue of $171.58 billion and a weighted average PE ratio of 43.22.
Market Cap
788.59B
Revenue
171.58B
Profits
18.25B
PE Ratio
43.22
Profit Margin
10.63%
Dividend Yield
0.21%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 214.34B | 0.05% | 2,264,793 | 46.34B |
| 2 | DHR | Danaher Corporation | 137.90B | -0.16% | 4,952,749 | 25.11B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.08B | -1.93% | 513,163 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 39.18B | -1.13% | 1,955,110 | 7.23B |
| 5 | IQV | IQVIA Holdings Inc. | 39.14B | -3.95% | 1,704,463 | 16.98B |
| 6 | NTRA | Natera, Inc. | 38.62B | 6.24% | 1,184,138 | 2.50B |
| 7 | WAT | Waters Corporation | 37.34B | 0.22% | 783,110 | 3.77B |
| 8 | ILMN | Illumina, Inc. | 31.03B | 5.27% | 2,770,355 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 27.90B | -0.56% | 203,546 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.86B | -0.39% | 947,709 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.53B | 2.73% | 1,398,617 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 20.36B | 5.75% | 2,734,442 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.14B | -1.13% | 318,297 | 2.78B |
| 14 | ICLR | ICON Public Limited Company | 12.77B | -7.10% | 1,774,131 | 8.29B |
| 15 | RVTY | Revvity, Inc. | 12.67B | 0.15% | 2,036,978 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 11.30B | -0.08% | 937,734 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.57B | -0.86% | 2,833,815 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 6.42B | 5.34% | 515,539 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.69B | 6.86% | 1,656,859 | 409.48M |
| 20 | SHC | Sotera Health Company | 5.09B | 1.83% | 1,684,786 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.93B | -1.07% | 524,574 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.77B | 7.31% | 1,551,155 | 561.90M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.85B | 7.18% | 5,284,113 | 308.08M |
| 24 | GRAL | GRAIL, Inc. | 3.05B | 12.14% | 546,420 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 2.05B | 8.27% | 841,287 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 2.04B | 3.99% | 5,303,452 | 766.30M |
| 27 | CDNA | CareDx, Inc. | 1.97B | 7.60% | 1,741,528 | 458.09M |
| 28 | PSNL | Personalis, Inc. | 1.29B | 4.69% | 2,743,197 | 64.52M |
| 29 | FRNM | Freenome, Inc. | 1.13B | -0.70% | 582,106 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 996.35M | -2.20% | 3,222,997 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 812.54M | 9.53% | 716,333 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 573.98M | 2.90% | 277,726 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 507.19M | 6.55% | 2,156,225 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 220.94M | 4.69% | 44,778 | 96.10M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 148.53M | 5.26% | 96,075 | 1.95M |
| 36 | XGN | Exagen Inc. | 112.83M | 7.36% | 98,936 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 93.34M | 0.34% | 2,479 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 37.87M | -3.02% | 149,000 | 25.83M |
| 39 | QUCY | Quantum Cyber N.V. | 25.27M | 4.72% | 370,292 | 537.08K |
| 40 | MDXH | MDxHealth SA | 20.94M | 1.87% | 120,326 | 110.97M |
| 41 | ADVB | Advanced Biomed Inc. | 16.65M | -8.20% | 149,476 | - |
| 42 | XWEL | XWELL, Inc. | 9.20M | 2.83% | 23,292 | 28.83M |
| 43 | MBAI | Check-Cap Ltd. | 8.27M | 2.88% | 37,703 | - |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.50M | -2.70% | 24,105 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 2.92M | 10.15% | 180,011 | 5.66M |
| 46 | ISPC | iSpecimen Inc. | 2.63M | -3.68% | 23,120 | 1.03M |